Woodline Partners LP - FREELINE THERAPEUTICS HLDGS ownership

FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 17 filers reported holding FREELINE THERAPEUTICS HLDGS in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Woodline Partners LP ownership history of FREELINE THERAPEUTICS HLDGS
ValueSharesWeighting
Q4 2021$51,000
-42.7%
25,9320.0%0.00%0.0%
Q3 2021$89,000
-57.8%
25,9320.0%0.00%
-75.0%
Q2 2021$211,000
-33.9%
25,9320.0%0.00%
-42.9%
Q1 2021$319,000
-32.7%
25,9320.0%0.01%
-46.2%
Q4 2020$474,000
-85.3%
25,932
-87.4%
0.01%
-87.7%
Q3 2020$3,222,000206,4130.11%
Other shareholders
FREELINE THERAPEUTICS HLDGS shareholders Q2 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 1,379,843$11,246,0002.62%
Novo Holdings A/S 2,361,229$19,244,0000.85%
Ally Bridge Group (NY) LLC 401,747$3,274,0000.81%
SECTORAL ASSET MANAGEMENT INC 640,714$5,222,0000.42%
FRAZIER MANAGEMENT LLC 550,000$4,483,0000.41%
TFG Asset Management GP Ltd 750,000$6,113,0000.33%
Eventide Asset Management 2,485,656$19,757,0000.26%
AXA S.A. 1,111,510$9,058,0000.01%
Woodline Partners LP 25,932$211,0000.00%
WELLINGTON MANAGEMENT GROUP LLP 2,001,951$16,315,0000.00%
View complete list of FREELINE THERAPEUTICS HLDGS shareholders